Women's Health

The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), the first randomized trial to compare two types of digital mammography for breast cancer screening, is now open for enrollment. The study was developed by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and the National Cancer...

When it comes to breast imaging, mammography has long been the gold standard among breast cancer detection technologies. But as the cancer-masking effects and increased risks of dense fibroglandular breast tissue become better understood by both healthcare professionals and patients, mammography...

Hologic Inc. announced that Steve MacMillan, the company's chairman, president and CEO, joined selected employees to ring the Nasdaq Opening Bell on October 2 in conjunction with the start of Breast Cancer Awareness Month. This is the 12th consecutive year Hologic rang the bell for Breast Cancer...

The U.S. Food and Drug Administration (FDA) cleared GE Healthcare’s Senographe Pristina with Self-Compression, the first 2-D digital mammography system that allows patients to increase or decrease the amount of compression applied to their own breast before the mammogram X-ray is taken.

Hologic Inc. announced U.S. commercial availability of the Brevera breast biopsy system with CorLumina imaging technology, a real-time breast biopsy and verification system. The system enhances workflow, improves the patient experience and streamlines the entire biopsy process from start to...